ID AFF2_MOUSE Reviewed; 1272 AA. AC O55112; B1ATW0; DT 27-APR-2001, integrated into UniProtKB/Swiss-Prot. DT 09-FEB-2010, sequence version 2. DT 27-MAR-2024, entry version 131. DE RecName: Full=AF4/FMR2 family member 2 {ECO:0000312|MGI:MGI:1202294}; DE AltName: Full=Protein FMR-2; DE Short=FMR2P; DE AltName: Full=Protein Ox19; GN Name=Aff2 {ECO:0000312|MGI:MGI:1202294}; Synonyms=Fmr2, Ox19; OS Mus musculus (Mouse). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae; OC Murinae; Mus; Mus. OX NCBI_TaxID=10090; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA]. RC TISSUE=Brain; RX PubMed=9467002; DOI=10.1093/hmg/7.3.441; RA Chakrabarti L., Bristulf J., Foss G.S., Davies K.E.; RT "Expression of the murine homologue of FMR2 in mouse brain and during RT development."; RL Hum. Mol. Genet. 7:441-448(1998). RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RC STRAIN=C57BL/6J; RX PubMed=19468303; DOI=10.1371/journal.pbio.1000112; RA Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S., She X., RA Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W., Kapustin Y., RA Meric P., Maglott D., Birtle Z., Marques A.C., Graves T., Zhou S., RA Teague B., Potamousis K., Churas C., Place M., Herschleb J., Runnheim R., RA Forrest D., Amos-Landgraf J., Schwartz D.C., Cheng Z., Lindblad-Toh K., RA Eichler E.E., Ponting C.P.; RT "Lineage-specific biology revealed by a finished genome assembly of the RT mouse."; RL PLoS Biol. 7:E1000112-E1000112(2009). RN [3] RP FUNCTION, AND SUBCELLULAR LOCATION. RX PubMed=19136466; DOI=10.1093/nar/gkn1058; RA Bensaid M., Melko M., Bechara E.G., Davidovic L., Berretta A., RA Catania M.V., Gecz J., Lalli E., Bardoni B.; RT "FRAXE-associated mental retardation protein (FMR2) is an RNA-binding RT protein with high affinity for G-quartet RNA forming structure."; RL Nucleic Acids Res. 37:1269-1279(2009). CC -!- FUNCTION: RNA-binding protein. Might be involved in alternative CC splicing regulation through an interaction with G-quartet RNA CC structure. {ECO:0000269|PubMed:19136466}. CC -!- SUBCELLULAR LOCATION: Nucleus speckle {ECO:0000269|PubMed:19136466}. CC Note=When splicing or transcription are inhibited, accumulates in CC large, rounded speckles and in the nucleolus. {ECO:0000250}. CC -!- TISSUE SPECIFICITY: Highly expressed in the hippocampus, the piriform CC cortex, Purkinje cells and the cingulate gyrus. CC -!- DEVELOPMENTAL STAGE: Expressed before day 7 in the embryo and reached CC its highest levels at 10.5-11.5 days. In the embryo at day 11, CC expression is more specific in the roof of the hind brain and the CC lateral ventricle of the brain. CC -!- SIMILARITY: Belongs to the AF4 family. {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AJ001549; CAA04821.1; -; mRNA. DR EMBL; AL663113; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; AL672120; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; AL808131; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; BX294655; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR CCDS; CCDS30173.1; -. DR PIR; T30248; T30248. DR RefSeq; NP_032058.2; NM_008032.3. DR AlphaFoldDB; O55112; -. DR SMR; O55112; -. DR BioGRID; 199717; 3. DR STRING; 10090.ENSMUSP00000033532; -. DR iPTMnet; O55112; -. DR PhosphoSitePlus; O55112; -. DR EPD; O55112; -. DR PaxDb; 10090-ENSMUSP00000033532; -. DR ProteomicsDB; 285734; -. DR Antibodypedia; 529; 181 antibodies from 23 providers. DR DNASU; 14266; -. DR Ensembl; ENSMUST00000033532.7; ENSMUSP00000033532.7; ENSMUSG00000031189.13. DR GeneID; 14266; -. DR KEGG; mmu:14266; -. DR UCSC; uc009tjb.1; mouse. DR AGR; MGI:1202294; -. DR CTD; 2334; -. DR MGI; MGI:1202294; Aff2. DR VEuPathDB; HostDB:ENSMUSG00000031189; -. DR eggNOG; ENOG502QR32; Eukaryota. DR GeneTree; ENSGT00950000182974; -. DR HOGENOM; CLU_006484_0_0_1; -. DR InParanoid; O55112; -. DR OMA; PKEKESM; -. DR OrthoDB; 4254515at2759; -. DR PhylomeDB; O55112; -. DR TreeFam; TF326216; -. DR BioGRID-ORCS; 14266; 2 hits in 81 CRISPR screens. DR ChiTaRS; Aff2; mouse. DR PRO; PR:O55112; -. DR Proteomes; UP000000589; Chromosome X. DR RNAct; O55112; Protein. DR Bgee; ENSMUSG00000031189; Expressed in undifferentiated genital tubercle and 76 other cell types or tissues. DR GO; GO:0016607; C:nuclear speck; IDA:UniProtKB. DR GO; GO:0005634; C:nucleus; IDA:MGI. DR GO; GO:0002151; F:G-quadruplex RNA binding; IDA:UniProtKB. DR GO; GO:0007611; P:learning or memory; IMP:MGI. DR GO; GO:0006397; P:mRNA processing; IEA:UniProtKB-KW. DR GO; GO:0010629; P:negative regulation of gene expression; IMP:MGI. DR GO; GO:0035063; P:nuclear speck organization; ISO:MGI. DR GO; GO:0010468; P:regulation of gene expression; ISO:MGI. DR GO; GO:0043484; P:regulation of RNA splicing; IDA:UniProtKB. DR GO; GO:0008380; P:RNA splicing; IEA:UniProtKB-KW. DR Gene3D; 6.10.250.2670; -; 1. DR InterPro; IPR007797; AF4/FMR2. DR InterPro; IPR043640; AF4/FMR2_CHD. DR InterPro; IPR043639; AF4_int. DR PANTHER; PTHR10528; AF4/FMR2 FAMILY MEMBER; 1. DR PANTHER; PTHR10528:SF18; AF4_FMR2 FAMILY MEMBER 2; 1. DR Pfam; PF05110; AF-4; 2. DR Pfam; PF18875; AF4_int; 1. DR Pfam; PF18876; AFF4_CHD; 1. DR Genevisible; O55112; MM. PE 2: Evidence at transcript level; KW mRNA processing; mRNA splicing; Nucleus; Phosphoprotein; KW Reference proteome; RNA-binding. FT CHAIN 1..1272 FT /note="AF4/FMR2 family member 2" FT /id="PRO_0000215913" FT REGION 151..190 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 204..231 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 372..401 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 422..497 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 557..694 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 715..743 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 772..899 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 162..190 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 206..231 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 384..401 FT /note="Basic and acidic residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 431..477 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 557..578 FT /note="Basic and acidic residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 591..605 FT /note="Basic and acidic residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 607..623 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 626..678 FT /note="Basic and acidic residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 679..693 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 715..738 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 810..831 FT /note="Basic and acidic residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 853..870 FT /note="Basic and acidic residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT MOD_RES 395 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:P51816" FT MOD_RES 482 FT /note="Phosphothreonine" FT /evidence="ECO:0000250|UniProtKB:P51816" FT CONFLICT 432 FT /note="P -> S (in Ref. 1; CAA04821)" FT /evidence="ECO:0000305" FT CONFLICT 544 FT /note="A -> S (in Ref. 1; CAA04821)" FT /evidence="ECO:0000305" FT CONFLICT 941 FT /note="V -> A (in Ref. 1; CAA04821)" FT /evidence="ECO:0000305" SQ SEQUENCE 1272 AA; 140181 MW; 1CE41F1AEFE9C2B4 CRC64; MDLFDFFRDW DLEQQCHYEQ DRSALKKREW ERRNQEVQQE EDLFSSGFDL FGEPYKVAEY TNKGDALANR VQNTLGSYDE MKDLLSNHSS QNHLVGIPKN SAPQTPISKS EASFYPEQKN RMIPSHQETT HSSTPMPPPS VVILNSTLIH SNRKSKSEWP RDSHNTSPAQ ASQTSSQPNK MQTSTQDPPQ TRLEDFFVYP AEQPQIGTVE KSNPSSKEEN NPNSGGEDTF KEIFQSNSPE ESEFTVQAPG SPLVASSLLA PSSGLSVPTF PPGLYCKTSM GQQKPTAYVR PMDGQDQATD ISPTLKPSIE FENSFGNLSF GSLLDGKPSA VSSKTKLPKF TILQTSEVSL TSDPSCVEEI LRESQHLTPG FTLQKWSDPS SRASTKMLED DLKLSSDEDD LEPVKTLTTQ CTANELYQAV EKAKPKNNPV NPLLATPQST PATQTNVGSG SSSESESSSE SDSDTESSTT DSESNEAPRV ATPEPEPPST NKWQLDKWLN KVTSQNKSFI CGQNETPTET ISLPPPIIQP VEVQVKVKPN PSQAVAVPKE RPLLSLIREK ARPRPTQKTP ETKALKHKLS TSVDTVSQRT IGKKQPKKVE KNTSFEEFTW PKPNITNSTP KEKGSVELPD PPRSRNKATA HKPVPRKEPR PHVPLATEKK KYRGPGKIVP KSREFIETDS STSDSNTDQE ETLQIKVLPP CITSKSKETS NASLTLSTLT NGNSNNLSTS NEETAFSPPP AMQTELLSPL RDHENPKNLW VKIDLDLLSR VPGQNSVPVT PAKTDYKETA SKPKRQTAAT AVEKPAPKGK RKHKPAETAE KIPEKKQRLE DNTTICLLPP CISPAPPHKP PSTRENSSRR ANRKKEEKLF PPALSPLAED PPRRRNVSGN NGHFGQDKNI SMAGQITSSK PKRSEGKFCA TFKGISINEG DAPKKAASAT VTVANMALAT ATATATVPAI VTATVTATAT TTATATTTTT TTTISSITPT ITSGLMDSSH LEMTSWAALP LLSSSSANVR RPKLTFDDSV HNADFYMQEA KKLKHKADAL FEKFGKAVNY ADAALSFTEC GNAMERDPLE AKSPYTMYSE TVELLRYAMR LKNFASPLAS DGDKKLAVLC YRCLSLLYLR MFKLKKDHAM KYSRSLMEYF KQNASKVTQI PSPWVGNGKN TPSPVSLNNV SPINSVGNCN NGPVTIPQRI HHMAASHVNI TSNVLRGYEH WDMADKLTRD NKEFFGDLDT LMGPLTQHSS MTNLVRYVRQ GLCWLRIDAH LL //